Related Experiment Videos
Topical pharmacotherapy for allergic rhinitis: nedocromil
1Department of Otolaryngology, University of Texas Southwestern Medical Center, Dallas 75235-9035.
American Journal of Otolaryngology
|November 1, 1993
Summary
Nedocromil sodium is a potent anti-inflammatory mast-cell stabilizer, offering an alternative to steroids for allergic responses. Its efficacy may allow for less frequent dosing compared to existing treatments.
Area of Science:
- Pharmacology
- Allergy and Immunology
- Inflammation Research
Background:
- Nedocromil sodium is a mast-cell stabilizer.
- It effectively prevents both acute and late phases of allergic reactions.
- It is a non-steroidal anti-inflammatory agent.
Purpose of the Study:
- To evaluate the efficacy and dosing potential of nedocromil sodium.
- To compare its potency with existing mast-cell stabilizers like cromolyn.
- To discuss its application in managing allergic responses.
Main Methods:
- Clinical trials for nasal administration.
- Pharmacological studies on mast-cell stabilization.
- Comparative analysis with cromolyn.
Main Results:
- Nedocromil sodium is more potent than cromolyn.
- Potential for less frequent maintenance therapy intervals.
- Pulmonary form is available; nasal form is in clinical trials.
Conclusions:
- Nedocromil sodium represents a potent, non-steroidal option for allergic response management.
- Its efficacy suggests potential for improved therapeutic regimens.
- Further development, including nasal administration, is ongoing.